Rivanol is for external use sterilization preservative, the gram positive bacteria and a few gram-negative bacteria have strong exterminate action, to cocci especially streptococcus antibacterial effect strong. It is used for all kinds of wounds, seepage, erosion of infectious skin disease and wound flushing.

The global Rivanol market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Rivanol volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rivanol market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Rivanol in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Rivanol manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
ESCO-PHARM
Chemax Pharma
Dermapharm AG
Galenfarm
HASCO Group
JSN Chemicals
Pasteur Romania
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Rivanol Powder
Rivanol Solution

Segment by Application
Individual
Commercial